Why do 95% of GenAI pilots show no measurable ROI?
Because most pilots are engineered to impress in a demo, not to move a business metric. Public reporting on a widely cited MIT study found that roughly 95% of enterprise generative-AI pilots produced no measurable profit-and-loss impact. The bottleneck is almost never the model. It is missing workflow integration, unclear ownership, unsolved data access, and no metric the pilot was ever meant to move.
- ▸The pilot was scoped to dazzle, not to change a process. A slick assistant that nobody is required to use changes no cost line and no revenue line.
- ▸No baseline was captured. If you never measured handle time, error rate, or cost-to-serve before, you cannot claim a delta after.
- ▸The model sits beside the workflow, not inside it. Value appears when the output lands in the system of record (CRM, ticketing, ERP), not in a chat window someone copies from.
- ▸Data access was underestimated. Retrieval over messy, permission-scoped internal data is most of the work and most of the reason answers come back wrong.
The teams that beat the odds treat GenAI like a software product with an owner and an SLA. For a menu of workflows that reliably return value, see AI Automation That Actually Pays Off: 7 High-ROI Use Cases.
What does the MIT 2026 finding actually say (and not say)?
The widely reported figure, sometimes called the GenAI Divide, is that around 95% of enterprise pilots showed no clear P&L return while a small minority captured most of the value. It is a statement about deployment discipline, not model capability. Treat the exact percentage as directional and verify it against the primary report before quoting it.
- ▸What it says: most organizations are stuck at the pilot stage; a few crossed into production and captured outsized returns. The dividing line was execution, buying and integrating focused tools instead of running sprawling internal science projects.
- ▸What it does not say: that GenAI does not work, or that the technology itself is the limiting factor. Capable models are increasingly a commodity; your data and your workflow are the moat.
- ▸An honesty note: headline numbers from a single study shift as methodology and samples change. Cite the figure as reported, link readers to the source, and do not treat 95% as a law of nature.
What separates the winning 5% from everyone else?
The winners pick one expensive, repetitive workflow, wire the model into the system of record, assign a named owner with a target metric, and instrument everything with evaluations and tracing before scaling. They treat GenAI as a product with service levels, not an experiment, and they kill features that do not move the metric.
- ▸Narrow scope, deep integration. One workflow taken end to end beats ten shallow demos.
- ▸A metric owner. A single person on the P&L hook, not a steering committee.
- ▸An evaluation harness first. Golden datasets and offline evals (RAGAS-style faithfulness and answer-relevancy) so you can prove a change is genuinely an improvement.
- ▸Observability. Tracing with Langfuse or LangSmith so production failures are debuggable instead of mysterious.
- ▸Human-in-the-loop where stakes are high, and full automation only where errors are cheap and reversible.
This is the same discipline that separates a chatbot from an automated workflow. See AI Agents in the Enterprise 2026: From Chatbots to Autonomous Workflows.
Should you build, buy, or nearshore your GenAI capability?
Buy the commodity, build the thin layer that encodes your proprietary workflow and data, and nearshore the sustained engineering that keeps both running. The classic failure is inverting this: building undifferentiated plumbing from scratch while buying a generic assistant that touches none of your real processes.
- ▸Buy: foundation-model APIs, managed vector search, and off-the-shelf orchestration. These are undifferentiated and improving faster than you can rebuild them.
- ▸Build: retrieval over your data, guardrails, the evaluation harness, and the integration into your ERP and CRM. This is where your advantage actually lives.
- ▸Nearshore: the ongoing engineering, meaning evals, prompt and version management, cost control, and incident response. A same-timezone team in the EU-North Africa corridor gives you continuity without offshore latency or handoff drag.
For the underlying decision framework, read Build vs Buy: When to Use SaaS and When to Build Custom Software.
Which metrics map GenAI to your P&L?
Pick metrics your CFO already tracks. Cost-to-serve, gross margin, cycle time, first-contact resolution, and revenue per employee move the P&L; token counts, prompt volume, and model leaderboards do not. Capture a baseline before the pilot, attribute the delta conservatively afterward, and net out the fully loaded cost of running the model.
- ▸Cost side: cost-to-serve, average handle time, ticket deflection rate, rework and error rate, engineer hours per shipped feature.
- ▸Revenue side: conversion rate, time-to-quote, churn, and upsell attach rate.
- ▸Quality side: first-contact resolution, CSAT, and defect escape rate.
- ▸Net it out: subtract fully loaded inference and retrieval cost, plus the human-review overhead you added to keep quality acceptable.
A pilot that saves ten minutes per ticket but doubles per-query cost may still lose money. Model the economics honestly with The Real Cost of Running an LLM in Production in 2026.
How long before a GenAI pilot should show a return?
Set a decision gate, not an open-ended runway. A focused single-workflow pilot should show a measurable movement in its target metric within roughly 8 to 12 weeks. If the baseline has not moved by then, either the scope was wrong or the integration is missing. Time-box it, review against the pre-agreed metric, then scale, pivot, or stop.
- ▸Weeks 1 to 2: capture the baseline and stand up the evaluation harness.
- ▸Weeks 3 to 8: integrate into the system of record and iterate on retrieval and prompts against your evals.
- ▸Weeks 9 to 12: measure against baseline and make an explicit decision.
- ▸Hedge: timelines vary with data readiness and integration surface. A workflow that needs new data pipelines built first will run longer, and that should be stated up front rather than discovered late.
What are the most common reasons pilots stall?
Pilots stall on data access, ownership, and integration, rarely on the model. The recurring killers are permission-scoped data nobody untangled, a proof-of-concept nobody was required to adopt, hallucinations with no evaluation to catch them, and runaway cost once real traffic arrived. Each is an engineering and governance problem, not a capability gap.
- ▸Data access and permissions: multi-tenant isolation and row-level security ignored until production.
- ▸No adoption mandate: optional tools get politely ignored.
- ▸Unmanaged cost: no token budgets, no caching, no model routing between cheap and expensive tiers.
- ▸Shadow AI: teams paste sensitive data into consumer tools with no oversight, creating risk without capturing value. See Shadow AI: The Governance Gap Every Engineering Team Now Has.
- ▸No governance: no evaluation gate, no owner, no rollback path when quality regresses.
How TuniCyberLabs helps
We take GenAI initiatives from stalled pilot to a production system with a metric attached. Our engineers scope one high-value workflow, build the retrieval and evaluation layer, integrate it into your ERP or CRM, and instrument cost and quality so the return is visible on the P&L, not just in a demo. We work in the EU-North Africa nearshore model, so the team that builds it is the team that keeps it running.
Tell us the workflow that costs you the most and we will scope a metric-driven pilot. Talk to our engineering team.